(Sharecast News) - Biotech investor International Biotechnology Trust has said that it expects the current wave of "frenetic" biotech M&A activity to continue after it was announced that its flagship portfolio company Soleno was acquired this week for $2.9bn.
Soleno Therapeutics, the rare diseases specialist whose lead candidate is a drug...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE